Spencer JF - Search Results

1

Characterization of an N-Terminal Non-Core Domain of RAG1 Gene Disrupted Syrian Hamster Model Generated by CRISPR Cas9.

Miao J, Ying B, Li R, Tollefson AE, Spencer JF, Wold WSM, Song SH, Kong IK, Toth K, Wang Y, Wang Z. Miao J, et al. Among authors: spencer jf. Viruses. 2018 May 6;10(5):243. doi: 10.3390/v10050243. Viruses. 2018. PMID: 29734775 Free PMC article.

2

Cotton rat tumor model for the evaluation of oncolytic adenoviruses.

Toth K, Spencer JF, Tollefson AE, Kuppuswamy M, Doronin K, Lichtenstein DL, La Regina MC, Prince GA, Wold WS. Toth K, et al. Among authors: spencer jf. Hum Gene Ther. 2005 Jan;16(1):139-46. doi: 10.1089/hum.2005.16.139. Hum Gene Ther. 2005. PMID: 15703497

3

Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression.

Kuppuswamy M, Spencer JF, Doronin K, Tollefson AE, Wold WS, Toth K. Kuppuswamy M, et al. Among authors: spencer jf. Gene Ther. 2005 Nov;12(22):1608-17. doi: 10.1038/sj.gt.3302581. Gene Ther. 2005. PMID: 16034456

4

Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors.

Thomas MA, Spencer JF, La Regina MC, Dhar D, Tollefson AE, Toth K, Wold WS. Thomas MA, et al. Among authors: spencer jf. Cancer Res. 2006 Feb 1;66(3):1270-6. doi: 10.1158/0008-5472.CAN-05-3497. Cancer Res. 2006. PMID: 16452178

5

Targeting interferon-alpha increases antitumor efficacy and reduces hepatotoxicity of E1A-mutated spread-enhanced oncolytic adenovirus.

Shashkova EV, Spencer JF, Wold WS, Doronin K. Shashkova EV, et al. Among authors: spencer jf. Mol Ther. 2007 Mar;15(3):598-607. doi: 10.1038/sj.mt.6300064. Epub 2006 Dec 26. Mol Ther. 2007. PMID: 17191072 Free article.

6

Immunocompetent, semi-permissive cotton rat tumor model for the evaluation of oncolytic adenoviruses.

Toth K, Spencer JF, Wold WS. Toth K, et al. Among authors: spencer jf. Methods Mol Med. 2007;130:157-68. doi: 10.1385/1-59745-166-5:157. Methods Mol Med. 2007. PMID: 17401171

7

Use of the Syrian hamster as an animal model for oncolytic adenovirus vectors.

Thomas MA, Spencer JF, Wold WS. Thomas MA, et al. Among authors: spencer jf. Methods Mol Med. 2007;130:169-83. doi: 10.1385/1-59745-166-5:169. Methods Mol Med. 2007. PMID: 17401172

8

Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model.

Toth K, Spencer JF, Dhar D, Sagartz JE, Buller RM, Painter GR, Wold WS. Toth K, et al. Among authors: spencer jf. Proc Natl Acad Sci U S A. 2008 May 20;105(20):7293-7. doi: 10.1073/pnas.0800200105. Epub 2008 May 19. Proc Natl Acad Sci U S A. 2008. PMID: 18490659 Free PMC article.

9

Immunosuppression enhances oncolytic adenovirus replication and antitumor efficacy in the Syrian hamster model.

Thomas MA, Spencer JF, Toth K, Sagartz JE, Phillips NJ, Wold WS. Thomas MA, et al. Among authors: spencer jf. Mol Ther. 2008 Oct;16(10):1665-73. doi: 10.1038/mt.2008.162. Epub 2008 Jul 29. Mol Ther. 2008. PMID: 18665155 Free PMC article.

10

Effect of preexisting immunity on oncolytic adenovirus vector INGN 007 antitumor efficacy in immunocompetent and immunosuppressed Syrian hamsters.

Dhar D, Spencer JF, Toth K, Wold WS. Dhar D, et al. Among authors: spencer jf. J Virol. 2009 Mar;83(5):2130-9. doi: 10.1128/JVI.02127-08. Epub 2008 Dec 10. J Virol. 2009. PMID: 19073718 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters